LymeNet Home LymeNet Home Page LymeNet Flash Discussion LymeNet Support Group Database LymeNet Literature Library LymeNet Legal Resources LymeNet Medical & Scientific Abstract Database LymeNet Newsletter Home Page LymeNet Recommended Books LymeNet Tick Pictures Search The LymeNet Site LymeNet Links LymeNet Frequently Asked Questions About The Lyme Disease Network LymeNet Menu

LymeNet on Facebook

LymeNet on Twitter




The Lyme Disease Network receives a commission from Amazon.com for each purchase originating from this site.

When purchasing from Amazon.com, please
click here first.

Thank you.

LymeNet Flash Discussion
Dedicated to the Bachmann Family

LymeNet needs your help:
LymeNet 2020 fund drive


The Lyme Disease Network is a non-profit organization funded by individual donations.

LymeNet Flash Post New Topic  New Poll  Post A Reply
my profile | directory login | register | search | faq | forum home

  next oldest topic   next newest topic
» LymeNet Flash » Questions and Discussion » General Support » Doctors Target Germs' Ability to Cluster

 - UBBFriend: Email this page to someone!    
Author Topic: Doctors Target Germs' Ability to Cluster
gusgus260
LymeNet Contributor
Member # 2120

Icon 1 posted      Profile for gusgus260     Send New Private Message       Edit/Delete Post   Reply With Quote 
Here is an article I found that may eventually help us. If someone already posted it, oh well---Go to Google and type in

Doctors Target Germs' Ability to Cluster

It sounds hopefull. Maybe, with a bit of prodding they could try it on the Lyme bacteria.
~ Gus

Posts: 175 | From Venice, FL USA | Registered: Feb 2002  |  IP: Logged | Report this post to a Moderator
treepatrol
Honored Contributor (10K+ posts)
Member # 4117

Icon 1 posted      Profile for treepatrol     Send New Private Message       Edit/Delete Post   Reply With Quote 
WASHINGTON - Think of germs as gangsters. One thug lurking on a corner you might outrun, but a dozen swaggering down the street? Yikes. Bacteria make their own gangs, clustering quietly in the body until there's a large enough group to begin an attack. This is the next frontier in fighting drug-resistant superbugs.

The idea: Don't just try to kill bacteria. The bugs will always find a way to thwart the next antibiotic.

The new goal is to disable bacteria's ability to sicken, so scientists can throw superbugs a one-two punch. And attempts to bust up germ gangs are leading the race to create these novel anti-infectives _ using everything from compounds in Pinot Noir to some popular bone-building drugs.

"It's a stealth approach," says chemist Kim Janda of the Scripps Research Institute, who is developing a vaccine against notorious drug-resistant staph that prevents the bacteria from ganging up.

"We're trying to find the Achilles heel in drug-resistant bacteria," adds Matthew Redinbo of the University of North Carolina, Chapel Hill _ who did find one.

Redinbo's team discovered that certain osteoporosis drugs blocked one E. coli germ from spreading antibiotic-resistance genes to another. Interrupting this recruitment of new gangsters confused the drug-resistant bugs enough that they committed suicide, leaving only easy-to-treat germs behind.

All of this research is in very early stages. But Dr. Julie Gerberding, chief of the Centers for Disease Control and Prevention, calls disarming bacteria a long-needed new approach.

It is "like lasers going in to destroy certain parts of the bacteria as opposed to a bomb that blows the whole thing up," Gerberding told Congress recently. These "next-generation strategies are not proven yet, but really something that needs a lot more attention and focus."

Indeed, despite a rise in bacteria that withstand today's best treatments, there are few novel antibiotics under development _ and germs have evolved such complex ways to survive antibiotics' frontal assault that new ones eventually will wear out, too.

Hence the quest to disarm germs. Scientists are trying to disable "virulence factors," molecules that help germs worm their way into the body, or block germ-emitted toxins.

But much of the new research centers on simply keeping germs from clustering.

"We're finding new ways to prevent disease without killing the microbial agent ... rather, neutralizing it somehow," says University of Rochester dentist Hyun Koo, who is using compounds left over from vineyards' wine-making to bust up gooey bacteria masses known as biofilms.

Adds Scripps' Janda: "If you break them up, they don't have that strength in number. They're not going to do like a gang and beat people up."

Among the methods under study:

_Germs talk to each other, by sending out radar-like chemical signals that sense when enough of their mates are lurking for them to switch on and sicken. Scientists call this "quorum sensing." Jam their frequencies, and the germs won't know when they've got a quorum _ they'll just hang around harmlessly until the immune system picks them off.

Janda's team designed a molecule that triggers the immune system to form bloodhound-like antibodies that gobble up the communication chemicals sent by deadly staph aureus bacteria. Janda injected some mice with those antibodies and others with a dummy drug. Then he gave all the mice a lethal dose of staph. The antibody-protected mice never got sick, while their unprotected neighbors died within a day.

_Other times germs need only to rub shoulders with a neighbor to start doing damage. Antibiotic-resistant E. coli snuggles up to a still treatable germ and shoots the newcomer with DNA that will turn it drug-resistant, too.

At UNC, Redinbo's team found the enzyme that sparks that whole process could be blocked by bone-building osteoporosis drugs already on the market, including one called etidronate. When they added just a bone drug, not antibiotics, to the drinking water of E. coli-infected mice, the rodents' bacteria levels plummeted. Why? The resistant germs not only couldn't spread their bad genes, they wound up committing suicide.

"This was a huge surprise," says Redinbo, who now is testing if the approach will work on other bacteria _ and is checking his hospital's records to see if women taking osteoporosis drugs just might be less vulnerable to hospital-spread infections.

_Then there are biofilms, where germs literally glue themselves together under a crusty shell difficult for antibiotics to penetrate. Rochester's Koo aims to break up cavity-causing dental plaque, the best known biofilm, with compounds called polyphenols culled from fermented grape skins.

A type of strep bacteria forms dental plaque, by secreting enzymes called GTFs that in turn produces the biofilm's glue. When Koo added polyphenols to lab dishes teeming with strep, GTF production plummeted 85 percent. The germs couldn't get sticky enough. For the record, extracts from Cabernet Franc and Pinot Noir worked best.

The approach should work against strep strains that cause pneumonia, too, Koo says. His ultimate goal is a cavity-preventing rinse, but much more research is required _ and Koo warns not to swish with wine in the meantime. It's too acidic.

"You'll wind up with stained teeth and also erosion from the acidity," he cautions.

--------------------
Do unto others as you would have them do unto you.
Remember Iam not a Doctor Just someone struggling like you with Tick Borne Diseases.

Newbie Links

Posts: 10564 | From PA Where the Creeks are Red | Registered: Jun 2003  |  IP: Logged | Report this post to a Moderator
gusgus260
LymeNet Contributor
Member # 2120

Icon 1 posted      Profile for gusgus260     Send New Private Message       Edit/Delete Post   Reply With Quote 
Treepatrol, thanks for posting the whole article.
"I see a light at the end of this long, dark tunnel, and I hope it not a train".
I don't know who came up with that quote, but they surely have been there.

Posts: 175 | From Venice, FL USA | Registered: Feb 2002  |  IP: Logged | Report this post to a Moderator
   

Quick Reply
Message:

HTML is not enabled.
UBB Code is enabled.

Instant Graemlins
   


Post New Topic  New Poll  Post A Reply Close Topic   Feature Topic   Move Topic   Delete Topic next oldest topic   next newest topic
 - Printer-friendly view of this topic
Hop To:


Contact Us | LymeNet home page | Privacy Statement

Powered by UBB.classic™ 6.7.3


The Lyme Disease Network is a non-profit organization funded by individual donations. If you would like to support the Network and the LymeNet system of Web services, please send your donations to:

The Lyme Disease Network of New Jersey
907 Pebble Creek Court, Pennington, NJ 08534 USA


| Flash Discussion | Support Groups | On-Line Library
Legal Resources | Medical Abstracts | Newsletter | Books
Pictures | Site Search | Links | Help/Questions
About LymeNet | Contact Us

© 1993-2020 The Lyme Disease Network of New Jersey, Inc.
All Rights Reserved.
Use of the LymeNet Site is subject to Terms and Conditions.